Office-use compounding in Kentucky

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The date, and the wrong date that circulatesHigh confidence

The human office-use regulation expired 17 October 2020 under Kentucky’s seven-year sunset for administrative regulations. A different date, 6 August 2019, circulates and is real but describes a different event — the withdrawal of a proposed amendment, which left the unamended regulation in force for another fourteen months. The veterinary-only replacement took effect 19 November 2020, leaving a thirty-three-day gap with no compounding-for-administration rule at all.A page publishing the 2019 date is checkably wrong against the legislature’s own expired-regulations table, and wrong in a way that shortens Kentucky’s permission by over a year.

The trap URL, and it is on the legislature’s own domainHigh confidence

The address numbered for the expired human rule returns a document titled for a different regulation number and containing a complete express office-use permission, including a "For Office or Institutional Administration Only" legend. It is an unfilled 2020 boilerplate template: it still carries placeholder text where a name, a date and an agency approval should be, and it is flagged inactive. It was never filed in any register and never took effect.Two different documents, the same rule number, one of them served from a state legislature at a URL numbered for a regulation that expired in 2020. Anyone who found that page and did not check the status flag has published an express-permission verdict for Kentucky. This page describes the artifact and does not cite it — the real veterinary rule lives at the adjacent number.

What binds nowHigh confidence

The statutory definition of compounding is tied to a valid prescription drug order or the anticipation of one, and the only quantity standard is "reasonable quantities". There is no sterile split: the compounding regulation applies the USP chapters in parallel and states one rule for any compounded preparation, sterile or non-sterile.

Two kinds of authority, and the split is the findingHigh confidence

Kentucky gives own-force authority to MOVE a legend drug — the distribution statute contains no federal reference at all, and the word "compound" does not appear in it — and federally-routed authority to MAKE one, because the compounding regulation’s own necessity clause says it establishes requirements in accordance with the federal compounding section. So the federal question is never escaped: the limb that would have to answer it is the limb that defers.

The 5% clause is real, and the regulator itself publishes it as the office-use answerHigh confidence

The Board’s own frequently-asked-questions page asks whether a pharmacy may sell prescription drugs to a practitioner for office use and answers yes. What that answer omits: it is an exemption from wholesale-distributor licensure and supply-chain transaction duties, it speaks of prescription drugs and stock bottles, and the word "compounded" appears in none of the office-use answers.This is the most dangerous false friend in the corpus, because the misdirection sits on a state government page a vendor can screenshot. The page also misstates its own statute twice — the statute measures against units dispensed by the pharmacy and says "does not exceed", while the page says "inventory" in one answer and "less than" in another. Cite the statute, not the page.

A live rule that has always cross-referenced a dead oneHigh confidence

The veterinary replacement cross-references a regulation that had already expired more than eight months before the veterinary rule took effect. The cross-reference has therefore pointed at nothing since the day the rule was born.

Entity or person — ownership-neutral, but the invoice must name a personMedium confidence

Kentucky does not restrict ownership in either direction. The practical constraint sits on the paperwork instead: the wholesale exemption runs to "a health-care practitioner", so an office-use sale invoiced to a management company is outside the carve-out on its face even where the underlying arrangement is unobjectionable.

Last change, and two dated aheadHigh confidence

The last office-use event was the 2020 expiry. The veterinary rule itself expires 19 November 2027 on the same seven-year clock, and the compounding regulation expires 25 October 2030. A separate enforcement fuse inside the compounding regulation fired on 1 January 2026, from which date the board enforces the 2022 revisions to the USP compounding chapters; the board took no action to delay it.A 2026 bill would have banned non-patient-specific human compounding by statute. It died in committee on 4 March 2026 without a hearing. It is not law and must not be described as one, but it is the clearest available signal of legislative direction.

Kentucky at a glance

Receiving 503B office stock in Kentucky

Kentucky is one of the states where the literal term works, and its receiving side is unusually clean — no practice permit, and no state controlled-substance registration at all. Claiming a Kentucky credential that does not exist is as damaging as missing one that does.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Kentucky asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

An outsourcing facility licence from the Board of Pharmacy, $250, the same in-state and out. Federal registration and a current federal inspection report are both preconditions, which is a higher documentary bar than most states in this file set.

Does your practice need a permit?High confidence

No — and this is a clean no rather than an inference. KRS 315.040(2) lets a physician keep any drug or medicine needed in practice, and the Board’s facility list carries no clinic category at all.

Administer vs dispenseMedium confidence

Neither act pulls a Kentucky practice into a facility credential. The operative constraint is upstream, on what a pharmacy may lawfully compound and supply, rather than downstream on what the practice does with it.

Scheduled (controlled) stockHigh confidence

None exists. Kentucky issues no state controlled-substance registration: the federal registration plus the Kentucky professional licence is the complete set, and the statute points expressly at federal registration. The state’s prescription monitoring account is a no-fee reporting account, not a credential, and should never be listed as one.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• The codified pre-2019 text of the expired human regulation is not in hand. A register redline proves the wording through its bracketed deletions, but we could not retrieve the codified text itself and the web archive was unreachable, so no pre-2019 quotation is published here.
• The commission’s published table of regulations expired under the sunset statute is the source of the 17 October 2020 date, and it is not currently reachable at a public URL — the address it was published at now returns a 404, and no other page we located carries the table. It is therefore named here but not linked, rather than linked to a page that does not contain it.
• We searched no case law or attorney-general opinions construing the distribution statute or the "reasonable quantities" standard. A source reading the distribution provision as reaching compounded stock, or glossing the quantity standard, would move Kentucky from silent toward narrow.
• The Board’s joint statement on compounding uses "should" rather than "shall", and the Board states that its declaratory rulings are not binding. Both are regulator expectations rather than law, and are reported that way.
• Search engines were unavailable when this page was researched, so we have not surveyed board newsletters, declaratory rulings, disciplinary orders or trade coverage for this state. Read nothing into that silence — it means we have not looked, not that nothing is there.